www.medicinapropraxi.cz / Med. Praxi. 2025;22(2):80-85 / MEDICÍNA PRO PRAXI 93 PŘEHLEDOVÉ ČLÁNKY Vitamin D a jeho klinické využití 6. Bergwitz C, Jüppner H. Regulation of phosphate homeostasis by PTH, vitamin D and FGF-23. Annu Rev Med. 2010;61:91-104. 7. Dominguez LJ, Farruggia M, Veronese N, Barbagallo M. Vitamin D sources, metabolism, and deficiency: available compounds and guidelines for its treatment. Metabolites. 2021;11,255. 8. Christakos S, Dhawan A, Verstuyf L, et al. Vitamin D: metabolism, molecular mechanism of action and pleiotropic effects. Physiological Reviews. 2016;96:365-408. 9. Keum N, Chen Q-Y, Lee DH, et al. Vitamin D supplementation and total cancer incidence and mortality by daily vs. infrequent large bolus dosing strategies: a metaanalysis of randomised controlled trials. Br J Cancer. 2022;127:872-878. 10. Rosen CJ, Adams JS, Bikle DD, et al. The nonskeletal affects of vitamin D: an endocrine society scientific statement. 2012;33:456-492. 11. Athanassiou L, Mavragani CP, Koutsilieris M. The immunomodulatory properties of vitamin D. Mediterr J Rheumatol. 2022;33:7-13. 12. Menzes AR, Lamb MC, Lavie CJ, et al. Vitamin D and atherosclerosis. Current Opinion in Cardiology. 2014;29:571-577. 13.Cashman KD, Dowling KG, Škrabáková Z, et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr. 2016;103:1033-1044. 14. Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the Prevention of Disease: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2024;109:1907-1947. 15. Giustina A, Bilezikian JP, Adler RA, et al. Consensus statement on vitamin D status assessment and supplementation: whys, whens, and hows. Endocrine Reviews. 2024;45:625-654. 16. Biasucci G, Donini V, Cannalire G. Rickets types and treatment with vitamin D and analogues. Nutrients. 2024;16:416. 17. Arboleya L, Brana I, Pardo E, et al. Osteomalacia in adults: a practical insight for clinicians. J Clin Med. 2023;12:2714. 18. Gaksch M, Jorde R, Grimnes G, et al. Vitamin D and mortality: individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium. PLOS One. 2017;12:e0170791. 19. Aspelund T, Grübler MR, Smith AV et al. Effect of genetically low 25-hydroxyvitamin D on mortality risk: mendelian randomization analysis in 3 large European cohorts. Nutrients. 2019;11:74. 20. Manson JE, Cook NR, Lee I-M, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380:33-44. 21. Martineau AR, Jolliffe DA, Hooper RI, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ 2017;356:i:6583. 22. Rasoul MA, Al-Mahdi M, Al-Kandari H, et al. Low serum vitamin D status is associated with high prevalence and early onset of type-1 diabetes mellitus in Kuwait. BMC Pediatr. 2016;16:95-95. 23. Jacobsen R, Moldovan M, Vaag AA, et al. Vitamin D fortification and seasonality of birth in type 1 diabetic cases.: D-tect study. J Devel Orig Health Dis. 2016;7:114-119. 24. Dong J-Y, Zhang W, Chen JJ, et al. Vitamin D intake and risk of type 1 diabetes: a meta-analysis of observational studies. Nutrients. 2013;5:3551-3562. 25. Kayaniyil S, Vieth R, Retnakaran R, et al. Association of vitamin D with insulin resistance and β-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care. 2010; 331379-1381. 26. Kahawara T, Suzuki G, Inazu T, at al. Rationale and design of diabetes prevention with active vitamin D (DPVD): a randomised, double-blind, placebo-controlled study. BMJ Open. 2016;6:e011183. 27. Bouillon R. Comparative analysis of nutritional guidelines for vitamin D. Nat Rev Endocrinol. 2017;13:466-479. 28. Chel V, Wijnhoven HAH, Smit JH, et al. Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporos Int. 2008;19:663-671. 29. Fassio A, Adami G, Rossini M, et al. Pharmacokinetics of oral cholekalciferol in healthy subjects with vitamin D deficiency: a randomized open-label study. Nutrients. 2020;12:1553. 30. De Niet S, Coffiner M, Da Silva S et al. A randomized study to compare a monthly to daily administration of vitamin D3 supplementation. Nutrients. 2018;10:659. 31. Rothen J-P, Rutishauser J, Walter PN, et al. Oral intermitent vitamin D substitution: influence of pharmaceutical form and dosage frequency on medication adherence: a randomized clinical trial. BMC Pharmacol Toxicol. 2020;21:51. 32. Giustina A, di Fillipo L, Allora A, et al. Vitamin D and malabsorptive gastrointestinal conditions: a bidirectional relationship? Rev Endocr Metab Disord. 2023;24:121-138. 33. Camacho PM, Petak SM, Binkley N, et al. American association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update executive summary. Endocr Pract. 2020; 26564-570. 34. Minisola S, Cianferotti L, Biondi P, et al. Correction of vitamin D status by calcidiol: pharmacokinetic profile, safety, and biochemical effects on bone and mineral metabolism of daily and weekly dosage regimens. Osteoporos Int. 2017;28:3239-3249. 35. Vieth R. Vitamin D supplementation: cholecalciferol, calcifediol, and calcitriol. Eur J Clin Nutr. 2020;74:1493-1497. ODBORNÝ GARANT: MUDr. Pavel Rutar Interní oddělení, Nemocnice Na Homolce, Praha POŘADATEL: Společnost SOLEN, s. r. o., ve spolupráci s Interním oddělením, Nemocnice Na Homolce PARTNEŘI: POČET KREDITŮ 2 Registrace ZDARMA TERMÍN květen 2025 až duben 2026 dostupný na online.solen.cz ON LINE KURZ OBSAH KURZU Management MASLD – diagnostika jaterní brózy v primární péči MUDr. Václav Šmíd, Ph.D. 21. století: nastal čas pro optimální suplementaci železem doc. MUDr. Jiří Slíva, Ph.D., MBA Broncho-Vaxom v prevenci opakovaných respiračních infekcí MUDr. Mojmír Račanský Přednáška sponzorovaná společností 4 Life Pharma CZ, s.r.o. Cestovní medicína pro praxi – MUDr. Milan Trojánek, Ph.D. 1 2025 Medicína pro praxi
RkJQdWJsaXNoZXIy NDA4Mjc=